1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
"Commercialization Readiness Program – Cooperative Agreement (UB1)" is currently closed and not accepting applications.
Commercialization Readiness Program – Cooperative Agreement (UB1) is sponsored by National Institutes of Health (NIH). Provides follow-on awards to small businesses for technology development, testing, evaluation, and commercialization assistance for SBIR or STTR Phase II technologies.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Commercialization Readiness Program – Cooperative Agreement (UB1) | Grants & Funding U.S. Department of Health and Human Services National Institutes of Health Commercialization Readiness Program – Cooperative Agreement (UB1) To support follow-on awards to small businesses for technology development, testing, evaluation, and commercialization assistance for SBIR or STTR Phase II technologies or for awards to small businesses to support the progress of research, research and development, and commercialization conducted under the SBIR or STTR programs to Phase III.
Only United States small business concerns (SBCs) that have had an active NIH SBIR or STTR Phase II or Phase IIB contract, grant or cooperative agreement from NIH within the last 36 months are eligible. Carefully read the Eligibility section of the funding opportunity for opportunity-specific organization eligibility requirements. Only one CRP award is allowed per project.
Standard Due Dates apply. Standard Application Due Dates (when applicable) NIH Grants Policy Statement Section 18. 5 Small Business Innovation Research and Small Business Technology Transfer Programs For technical issues E-mail OER Webmaster
According to the current listing, eligibility includes: U.S. small business concerns with active NIH SBIR or STTR Phase II or Phase IIB contracts, grants, or cooperative agreements within the last 36 months. Confirm the full requirements in the official notice before applying.
The published deadline was April 5, 2025, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Commercialization Readiness Program – Cooperative Agreement (UB1) is funded by National Institutes of Health (NIH). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
PA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read articlePA-27-034, PA-27-035 and PA-27-036 replace the institute-specific R25 announcements that research education programs have been built around for a decade. NCI, NIDA and NIGMS have already expired theirs early. Here is what the consolidation actually changes: an 8% indirect cost ceiling, a US-citizens-and-permanent-residents participant rule, a cooperative agreement variant that only exists on one of the three, and no clinical-trial-allowed companion anywhere.
Read article